Herophilus

Herophilus is a neurotherapeutics company headquartered in San Francisco, dedicated to treating complex brain disorders. Formerly known as System1 Biosciences, the company combines brain organoid science, systems neuroscience approaches, robotic automation, and advanced machine learning technologies to scale its ability to discover new drugs for complex neurological and psychiatric disorders. Herophilus employs an industry-first approach using multimodal phenotypic screening to uncover unprecedented disease signatures.